Tonix Pharmaceuticals Presents Positive Results from Phase 3 RELIEF Study of TNX-102 SL for the Management of Fibromyalgia at the 2021 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting

NEXT STORY
IGM Biosciences Announces Expansion of IgM Platform into Infectious Diseases, Publication of Preclinical Data in Nature Demonstrating Engineered IgM Antibody Antiviral Activity for the Treatment and Prevention of COVID-19
PREV STORY
Medical Non-Woven Disposables Market 2021 | Size, Share, Growth, Trends, Revenue, Competitive Analysis, Forecast Report
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

CELYAD S.A.: Celyad Announces Results for the CHART-1 Phase III Clinical Trial Evaluating C-Cure(R) Cell Therapy

A statistically-significant difference on the primary endpoint was not reached; however, a positive trend ...

author_avatar
NASDAQ Market News

Vaxil Announces Private Placement Extension

author_avatar
NASDAQ Market News

American Gene Technologies to Present at 2019 Cell & Gene Meeting on the Mesa

author_avatar
NASDAQ Market News